Results 11 to 20 of about 17,947 (225)
Effect of combining CBD with standard breast cancer therapeutics
Advances in Cancer Biology - Metastasis, 2022 Breast cancer is the most common malignancy in women worldwide. Sixty-five percent of breast cancers are estrogen and/or progesterone receptor positive.
Luka Dobovišek +5 more
doaj +1 more source
Combination therapy with cannabidiol and chemotherapeutics in canine urothelial carcinoma cells.
PLoS ONE, 2021 BackgroundCanine urothelial carcinoma is the most common form of canine bladder cancer. Treatment with chemotherapy has variable response rates leading to most dogs succumbing to their disease within a year.
Jordon M Inkol +2 more
doaj +2 more sources
Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration. [PDF]
PLoS ONE, 2014 Disc degeneration is a multifactorial process that involves hypoxia, inflammation, neoinnervation, accelerated catabolism, and reduction in water and glycosaminoglycan content.
João W Silveira +7 more
doaj +1 more source
CANNABIDIOL- PROVOKES OR TREATS ANXIETY DISORDERS?
European Psychiatry, 2023 Introduction After the introduction of proposal regarding cannabidiol for the treatment of some psychiatric disorders including anxiety, there is confusion if cannabidiol use is associated with the provocation of anxiety symptoms or it can be safely ...
H. Arshad +5 more
doaj +1 more source
Cannabidiol regulation of learned fear: implications for treating anxiety-related disorders
Frontiers in Pharmacology, 2016 Anxiety and trauma-related disorders are psychiatric diseases with a lifetime prevalence of up to 25%. Phobias and post-traumatic stress disorder (PTSD) are characterized by abnormal and persistent memories of fear-related contexts and cues.
Regimantas Jurkus +5 more
doaj +1 more source
Cannabidiol markedly alleviates skin and liver fibrosis
Frontiers in Pharmacology, 2022 Cannabidiol (CBD) has been suggested as a potential therapy for inflammatory and fibrotic diseases. Cannabidiol was demonstrated to reduce alcohol-induced liver inflammation and steatosis but its specific activity on the fibrotic process was not ...
Carmen del Río +12 more
doaj +1 more source
Cannabidiol in the Treatment of Epilepsy [PDF]
Clinical Drug Investigation, 2021 Anecdotal reports addressing the successful seizure treatment of severe epilepsies with cannabidiol (CBD) have increased both public interest and academic research. Placebo-controlled, randomized, controlled trials proved the efficacy of pharmaceutical-grade CBD in epilepsy treatment, thus leading to pharmaceutical-grade CBD approval by the US Food and
von Wrede, Randi +2 more
openaire +2 more sources
Regulation of Innate Lymphoid Cells in Acute Kidney Injury: Crosstalk between Cannabidiol and GILZ
Journal of Immunology Research, 2020 Innate lymphoid cells (ILCs) have emerged as largely tissue-resident archetypal cells of the immune system. We tested the hypotheses that renal ischemia-reperfusion injury (IRI) is a contributing factor to polarization of ILCs and that glucocorticoid ...
Babak Baban +5 more
doaj +1 more source
Pharmaceutics, 2023 Cannabidiol (CBD) has previously been shown to inhibit inflammatory cytokine production in both in vitro and in vivo studies of neurodegenerative diseases.
Ilya Eydelman +5 more
doaj +1 more source
Pharmaceutics, 2023 There is potential for cannabidiol to act as an analgesic, anxiolytic and antipsychotic active ingredient; however, there is a need to find alternate administration routes to overcome its low oral bioavailability.
Zahra Khabir +5 more
doaj +1 more source